Dynavax (DVAX) Bullish Stance Reiterated at Jefferies Following R&D Day
Tweet Send to a Friend
Jefferies analyst Thomas Wei reiterated a Buy rating and $30 price target on Dynavax Technologies (NASDAQ: DVAX) following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
